ClinicalTrials.Veeva

Menu

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children (BudER)

D

Deborah Gentile

Status and phase

Completed
Phase 4

Conditions

Asthma

Treatments

Drug: Usual care (albuterol with or without oral steroid)
Drug: Nebulized Budesonide

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00189436
BUD ER 3425
RC - 3425 (Other Identifier)

Details and patient eligibility

About

Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period.

Full description

Secondary outcomes include urinary cortisol-creatinine rations, symptom severity scores and peak flow rates.

Enrollment

61 patients

Sex

All

Ages

1 to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children ages 1-8 years old
  • Discharge from emergency department/outpatient clinic with a diagnosis of asthma exacerbation after usual standard care
  • Subjects must be able to show efficient use with a jet nebulizer

Exclusion criteria

  • Subjects requiring hospitalization
  • Subjects receiving oral steroids 1 week prior to presentation to emergency department.
  • Subjects with FEV1 < 50% of predicted
  • Subjects with co-morbid medical conditions (renal or cardiovascular disease)
  • Subjects with reported history of HIV
  • Subjects unable to follow up for study visits
  • Subjects who are frequently enuretic

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

61 participants in 2 patient groups

Treatment with Budesonide
Active Comparator group
Description:
Subject is treated with nebulized budesonide 0.5 BID for 3 weeks
Treatment:
Drug: Nebulized Budesonide
Usual care
Active Comparator group
Description:
Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.
Treatment:
Drug: Usual care (albuterol with or without oral steroid)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems